Causes of Hodgkin's Lymphoma Treatment
Chemotherapy is the most common treatment for Hodgkin's lymphoma. It involves using anti-cancer drugs to destroy lymphoma cells throughout the body.
Radiation uses high-energy rays to target and kill cancer cells in specific lymph nodes or areas.
This treatment uses the body's immune system to identify and destroy cancer cells.
Targeted therapies attack specific abnormalities in cancer cells.
Involves replacing damaged bone marrow with healthy stem cells.
For some patients, enrolling in clinical trials offers access to cutting-edge therapies not yet widely available.
Before the Procedure
During the Procedure
After the Procedure
Hodgkin's lymphoma is a type of cancer that affects the lymphatic system, a part of the immune system. It is characterized by the presence of Reed-Sternberg cells in the lymph nodes.
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and persistent fatigue.
Yes, Hodgkin's lymphoma is one of the most curable forms of cancer, especially when detected early and treated appropriately.
The main treatment options include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplants.
The five-year survival rate for early-stage Hodgkin's lymphoma can be as high as 90%, depending on factors like age, health, and response to treatment.
Hair loss is a common side effect of chemotherapy, but it is usually temporary and hair typically regrows after treatment ends.
Many patients continue to work during treatment, though adjustments may be needed based on side effects and energy levels.
ABVD is a common chemotherapy regimen for Hodgkin's lymphoma that includes Adriamycin, Bleomycin, Vinblastine, and Dacarbazine.
Treatment duration varies but typically lasts between 3 to 6 months depending on the stage and type of treatment plan.
Some patients may experience long-term effects such as fatigue, heart or lung issues, or risk of secondary cancers, especially after radiation.
Radiation therapy is commonly used but not always necessary; it depends on the stage and how the cancer responds to chemotherapy.
A stem cell transplant replaces damaged bone marrow and is often used when Hodgkin's lymphoma returns after initial treatment.
Yes, in some cases, the disease may relapse. Re-treatment options include more aggressive chemotherapy, immunotherapy, or stem cell transplant.
Hodgkin's lymphoma is defined by the presence of Reed-Sternberg cells, whereas Non-Hodgkin's lymphoma includes a wider range of lymphatic cancers without these cells.
Yes, although rare, Hodgkin's lymphoma can occur in children and adolescents and is treated similarly to adults.
Follow-up typically occurs every 3 to 6 months for the first couple of years and less frequently afterward to monitor for relapse.
Yes, some treatments can affect fertility. Patients are encouraged to discuss fertility preservation options before starting treatment.
Maintaining a healthy diet, getting adequate rest, and avoiding infections are important during treatment. Always consult your oncologist for personalized advice.
Yes, if left untreated, Hodgkin's lymphoma can spread to other lymph nodes and organs like the lungs, liver, or bone marrow.
Look for a board-certified hematologist/oncologist with experience in treating Hodgkin's lymphoma and access to advanced treatment facilities.